DuranteWSchaferAI. Carbon monoxide and vascular cell function. Int J Mol Med.1998;2:255–262.
6.
WangXLSimASBadenhopRF. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med.1996;2:41–45.
7.
IchiharaSYamadaYFujimuraT. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol. 1998;81:83–86.
8.
HooperWCLallyCAustinH. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest. 1999;116:880–886.
9.
GensiniGFComeglioMColellaA. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J.1998;19(Suppl A):53–61.
10.
ThibonnierMGravesMKWagnerMS. Study of V1-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol. 2000;32:557–564.
11.
RehemudulaDNakayamaTSomaM. Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. Circ Res.1999;84:605–610.
12.
BrayMSBoerwinkleE. The role of beta(2)-adrenergic receptor variation in human hypertension. Curr Hypertens Rep.2000;2:39–43.
13.
von BeckerathNKastratiAKochW. G protein β3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis. 2000;149:151–155.
14.
ItoDMurataMWatanabeK. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke. 2000;31:936–939.
15.
BrayPF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol. 2000;7:284–289.